Titel	Veröffentlichungsdatum	Sprache	Zitate
Unleashing the immune system: PD-1 and PD-Ls in the pre-treatment tumor microenvironment and correlation with response to PD-1/PD-L1 blockade	2014/11/02	English	55
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells	2014/07/03	English	55
Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+PD-L1+phenotype in prostate cancer	2014/09/02	English	55
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy	2014/07/03	English	55
A model for cancer-suppressive inflammation	2012/10/01	English	54
Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression	2012/10/01	English	54
Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients	2012/11/01	English	54
PD-L1 expression and tumor-infiltrating lymphocytes	2014/06/01	English	54
Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells	2014/09/01	English	53
Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumors	2015/02/01	English	53
Sustained CD4+T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide	2014/01/01	English	53
Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation	2013/11/01	English	53
Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab	2014/08/03	English	52
Intratumoral alterations of dendritic-cell differentiation and CD8+T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma	2012/11/01	English	52
The CCL5/CCR5 axis promotes metastasis in basal breast cancer	2013/04/01	English	52
Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma	2012/08/01	English	52
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+T cells by plasmacytoid dendritic cells	2013/03/01	English	51
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4+T effector cells in patients with head and neck squamous cell carcinoma	2012/08/01	English	51
Lenalidomide induces degradation of IKZF1 and IKZF3	2014/07/03	English	51
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39	2012/05/01	English	50
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer	2013/07/01	English	50
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity	2013/03/01	English	50
Carcinoma origin dictates differential skewing of monocyte function	2012/09/01	English	49
Hypoxia-driven immunosuppression contributes to the pre-metastatic niche	2013/01/01	English	49
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma	2015/02/01	English	49
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cells	2013/04/01	English	48
Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+dendritic cells	2012/08/01	English	48
Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells	2012/09/01	English	48
Trial Watch	2013/05/01	English	47
Tumor-infiltrating B cells	2012/10/01	English	47